Results 81 to 90 of about 98 (96)

Postmarketing surveillance evaluating the safety and effectiveness of golimumab in Japanese patients with rheumatoid arthritis

Modern Rheumatology, 2018
Atsushi Kawakami, Shigeki Momohara, Momohara Shigeki   +2 more
exaly  

Sample Size and Postmarketing Surveillance

Drug Information Journal, 1985
Fred Schneiweiss
exaly  

Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study

Modern Rheumatology, 2019
Tatsuya Atsumi, Takao Fujii, Tsuneyo Mimori   +2 more
exaly  

Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance

Frontiers in Pharmacology, 2022
exaly  

Efficacy and safety of garenoxacin tablets on bacterial pneumonia: Postmarketing surveillance in Japan

Journal of Infection and Chemotherapy, 2014
Tadashi Ishida, Koichi Izumikawa, Naoyuki Miyashita   +2 more
exaly  

Detecting Adverse Drug Reactions in Postmarketing Surveillance: Interview Validity

Drug Information Journal, 1987
Seymour Fisher
exaly  

Postmarketing surveillance. Is not used to promote products.

BMJ (Clinical research ed.), 1994
openaire   +1 more source

Policosanol: results of a postmarketing surveillance study of 27,879 patients

Current Therapeutic Research, 1998
Julio Cesar Fernandez Travieso, Lilia Fernández, Rosa Mas   +2 more
exaly  

Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: Postmarketing surveillance in Japan

Journal of Infection and Chemotherapy, 2014
Tadashi Ishida, Koichi Izumikawa, Naoyuki Miyashita   +2 more
exaly  

[Publications and postmarketing product surveillance: why and how?].

Annales francaises d'anesthesie et de reanimation, 1998
openaire   +1 more source